These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39127345)
1. Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy. Luo H; Yu X; Li P; Hu J; Li W; Li X; Chen M; Yu S Neuroscience; 2024 Oct; 557():1-11. PubMed ID: 39127345 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy. Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F Cells; 2020 Oct; 9(11):. PubMed ID: 33138150 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics. Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis. Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266 [TBL] [Abstract][Full Text] [Related]
5. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy. Luan M; Wei L; Sun Y; Chen J; Jiang Y; Wu W; Li F; Sun W; Zhu L; Wang Z; Deng J Parkinsonism Relat Disord; 2024 Oct; 127():107088. PubMed ID: 39111257 [TBL] [Abstract][Full Text] [Related]
6. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA. Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283 [TBL] [Abstract][Full Text] [Related]
7. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy]. Yan XM; Li PJ; Li W; Wang XM; Yu S Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052 [No Abstract] [Full Text] [Related]
8. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy. Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004 [TBL] [Abstract][Full Text] [Related]
9. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder. Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T Mov Disord; 2024 Aug; 39(8):1300-1309. PubMed ID: 38715177 [TBL] [Abstract][Full Text] [Related]
10. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease. Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T Front Immunol; 2019; 10():2253. PubMed ID: 31616427 [TBL] [Abstract][Full Text] [Related]
11. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy. Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813 [TBL] [Abstract][Full Text] [Related]